Reporting a Homozygous Case of Neurodevelopmental Disorder Associated With a Novel PRPF8 Variant
Molecular Genetics & Genomic Medicine · 2025
DOI: 10.1002/mgg3.70084 ↗Kurz gefasst
Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, 2025. Verfasst von Mohammad Reza Mirinezhad und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Neurodevelopmental Disorders. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
While recently identified heterozygous PRPF8 variants have been linked to various human diseases, their role in neurodevelopmental disorders (NDDs) remains ambiguous. This study investigates the potential association between homozygous PRPF8 variants and NDDs. Most PRPF8 variants are primarily associated with retinal diseases; however, we analyze a family with multiple members diagnosed with NDDs.
Methods
Using exome sequencing (ES), the cause of behavioral problems and intellectual disabilities (IDs) of two sisters from a consanguineous parents was solved, and the results confirmed by direct sanger sequencing method likewise protein modeling to assess the structural impact of the identified variant on the PRPF8 protein has been done.
Results
ES identified a novel homozygous variant, PRPF8 c.257G>T, p.R86M. To the best of our knowledge at the time of writing this manuscript, the mentioned variant has not been reported in relation to NDDs. Protein modeling provided another line of evidence proving the pathogenicity of the novel variant.
Conclusion
Our findings indicate that the p.R86M variant may disrupt normal protein function by changing its structure and probably its interaction, potentially leading to the observed neurodevelopmental phenotypes. This study highlights the first link between the PRPF8 variant and NDDs, suggesting a distinct role for specific PRPF8 variants in the etiology of NDDs. These results warrant further investigation into the mechanisms by which PRPF8 variants contribute to NDDs, emphasizing the need for comprehensive genetic screening in families with unexplained neurodevelopmental conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Blood Borne Infections Research Center, Academic Center for Education, Culture & Research (ACECR), Razavi Khorasan Branch, Mashhad, Iran.
- Department of Medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
- Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
- Pediatric Ward, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Pediatric Neurology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
ORCID-Profile: Arash Salmaninejad, M E Suzzane Lewis
Zitieren
APA
Mirinezhad, M. R., Mirzaei, F., Salmaninejad, A., Esfehani, R. J., Seyedtaghia, M. R., Farahmand, S., Toosi, M. B., Hashemian, S., & Lewis, M. E. S. (2025). Reporting a Homozygous Case of Neurodevelopmental Disorder Associated With a Novel PRPF8 Variant. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70084
Vancouver
Mirinezhad MR, Mirzaei F, Salmaninejad A, Esfehani RJ, Seyedtaghia MR, Farahmand S, et al. Reporting a Homozygous Case of Neurodevelopmental Disorder Associated With a Novel PRPF8 Variant. Molecular Genetics & Genomic Medicine. 2025. doi:10.1002/mgg3.70084
BibTeX
@article{Mirinezhad2025,
author = {Mirinezhad, Mohammad Reza and Mirzaei, Farzaneh and Salmaninejad, Arash and Esfehani, Reza Jafarzadeh and Seyedtaghia, Mohammad Reza and Farahmand, Sheyda and Toosi, Mehran Beiraghi and Hashemian, Somayyeh and Lewis, M E Suzzane},
title = {Reporting a Homozygous Case of Neurodevelopmental Disorder Associated With a Novel PRPF8 Variant},
journal = {Molecular Genetics & Genomic Medicine},
year = {2025},
doi = {10.1002/mgg3.70084}
}
EUVIMED